Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist licensed by the MHRA and recommended by NICE (TA875, 2023) for adults with obesity or overweight with comorbidities
Such approaches may also be useful in the AD/ADRD field
In AD animal models, FOS helped preserve gut microbial balance, reduced brain cell death, and decreased the buildup of harmful proteins, such as tau and A142 (Chen et al., 2017)
Cutting back on caffeine when starting phentermine can reduce some of these side effects, he adds
Alternatively, those with a BMI of 30 or higher may qualify without a specific weight-related medical condition
"The most common ones I see are fatigue that doesn't improve with rest, weight gain or the inability to lose weight, hair thinning or hair loss, dry skin, constipation, brain fog, and feeling cold all the time," reveals the doctor